JP3194650002
JP3194650002
OKINAWA CELLULAR
Loading chart...
Solid Quality Asset with Moderate Fluctuation
Healthy balance: Exemplary business financials (Health Score: 80/100) paired with moderate price swings for a single equity (±18.7% p.a.). The score (5/7) reflects the standard baseline for equities under SRI rules.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
5/7 Elevated
5 / 7 SRI Price Fluctuation & Beta
Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.2x).
Beta (Market Relation)
0.17x
DefensiveVolatility (5Y p.a.)
18.7% p.a.
5-Year HorizonMax Drawdown (5Y)
-16.5%
5-Year HorizonSharpe Ratio
1.08
Return / RiskElevated Risk / Growth: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Volatility Expansion (3Y > 5Y)
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +39.8% |
| 3 Years | 20.8% | -16.5% | 1.44 | +32.3% |
| 5 Years | 18.7% | -16.5% | 1.08 | +22.8% |
| 10 Years | 18.5% | -28.9% | 0.79 | +17.1% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections